Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
TranS1
company
About
TranS1 develops a portfolio of medical products and intellectual property in the area of advanced surgical medicine.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $12M
- Industries
- Biotechnology,Health Care,Life Science,Manufacturing,Medical Device,mHealth
- Founded date
- Jan 1, 2002
- Number Of Employee
- 101 - 250
- Operating Status
- Active
TranS1 develops a portfolio of medical products and intellectual property in the area of advanced surgical medicine. It began operation in 2002.TranS1 has its headquarters in Denver in Colorado. It operates as a subsidiary of The Quandary Group.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$12M
TranS1 has raised a total of
$12M
in funding over 2 rounds. Their latest funding was raised on
May 12, 2003 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 12, 2003 | Series B | $12M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
TranS1 is funded by 2 investors.
Sapient Capital Partners
and Cutlass Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Sapient Capital Partners
|
— | Series B |
Cutlass Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
